ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
ICER Plans Review of Treatments for High Cholesterol
The Institute for Clinical and Economic Review (ICER) announced plans to review Novartis' inclisiran and Esperion Therapeutics' Nexletol for the [...]
Advertisement
